Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onset of action of BLX000441-002 nasal spray in healthy volunteers
2004-002807-33Phase 2Completed
- Sponsor
- Biolipox AB
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cetirizine dinitrate in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Biolipox AB. Primary endpoint: Plasma exudation measured by alpha2-macroglobulin after histamine challenge. Started Oct 2004; status: completed.
02
Drugs
cetirizine dinitrate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2004-002807-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002807-33.